menu search

BNTX / BioNTech, Medigene Ink Immunotherapy Pact Against Cancer

BioNTech, Medigene Ink Immunotherapy Pact Against Cancer
BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer.  The initial term of the collaboration is three years. Read More
Posted: Feb 22 2022, 07:31
Author Name: Benzinga
Views: 110517

BNTX News  

Pfizer, BioNtech say flu-COVID shot generates immune response

By Reuters
October 26, 2023

Pfizer, BioNtech say flu-COVID shot generates immune response

Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the viru more_horizontal

Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman

By CNBC Television
October 16, 2023

Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman

Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, more_horizontal

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

By Forbes
October 16, 2023

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid. more_horizontal

Pfizer and BioNtech take big write-downs on Covid jab stocks

By Proactive Investors
October 16, 2023

Pfizer and BioNtech take big write-downs on Covid jab stocks

Covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs following a similar provision by partner Pfize more_horizontal

Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move

By Market Watch
October 16, 2023

Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move

Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 i more_horizontal

BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines

By Reuters
October 16, 2023

BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines

Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pf more_horizontal

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

By GlobeNewsWire
October 16, 2023

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c more_horizontal

Why Pfizer and BioNTech Stocks Zoomed Higher Today

By The Motley Fool
September 29, 2023

Why Pfizer and BioNTech Stocks Zoomed Higher Today

While people in this country aren't rushing in masses to get updated COVID booster vaccines, take-up has been encouraging. Many are worried about an a more_horizontal


Search within

Pages Search Results: